Evidence map›Paper›PMID 32481245›Full record

ArticleJournal of musculoskeletal & neuronal interactions2020

Effectiveness of intramuscular ergocalciferol treatment in a patient with osteomalacia and insufficiency fractures due to severe vitamin D deficiency after bariatric surgery.

Labrini Papanastasiou, Christos Gravvanis, Symeon Tournis, Athina Markou, Irene Giagourta, Konstantinos Lymperopoulos, Theodora Kounadi

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of musculoskeletal & neuronal interactions, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Labrini PapanastasiouUnit of Endocrinology and Diabetes Center, General Hospital of Athens 'G. Gennimatas', Athens, Greece.
Christos GravvanisUnit of Endocrinology and Diabetes Center, General Hospital of Athens 'G. Gennimatas', Athens, Greece.
Symeon TournisLaboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, National and Kapodistrian University of Athens, KAT Hospital, Athens, Greece.
Athina MarkouUnit of Endocrinology and Diabetes Center, General Hospital of Athens 'G. Gennimatas', Athens, Greece.
Irene GiagourtaUnit of Endocrinology and Diabetes Center, General Hospital of Athens 'G. Gennimatas', Athens, Greece.
Konstantinos LymperopoulosDepartment of Radiology, General Hospital of Athens 'G Gennimatas', Athens, Greece.
Theodora KounadiUnit of Endocrinology and Diabetes Center, General Hospital of Athens 'G. Gennimatas', Athens, Greece.
General Hospital of Athens G. Genimatas · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D (vitD) deficiency and bone loss may occur after bariatric surgery and hence, supplementation with high oral doses of vitD may be required. Alternatively, intramuscular depot ergocalciferol, which slowly releases vitD and bypasses the gastrointestinal tract, could be administrated. We present a case of severe vitD deficiency-osteomalacia after gastric bypass operation for morbid obesity, treated with ergocalciferol intramuscularly. A 45-year-old woman was presented with hip pain and muscle weakness, which led ultimately to immobilization in a wheelchair. Fifteen years ago, she underwent roux-en-Y gastric by-pass for morbid obesity. Occasionally, she was treated with multivitamin supplements. On admission, iron deficiency anaemia, vitD deficiency (25OHD: 3.7 ng/ml) and secondary hyperparathyroidism were revealed. Bone turnover markers (BTM) were elevated. Radiological evaluation demonstrated insufficiency fractures on the pubic and left femur and reduced BMD. Osteomalacia due to vitD deficiency and calcium malabsorption were diagnosed. Calcium citrate 500 mg qid and intramuscular ergocalciferol 600,000 IU every 20 days were initiated. One month later, musculoskeletal pain and weakness were resolved and the patient was mobilized. Few months later, vitD, BTM and BMD showed substantial improvement. Intramuscular ergocalciferol administration can improve the clinical and biochemical status and thus, is suggested to prevent and/or treat osteomalacia in such patients.

Indexed as

Bone Density Conservation AgentsDelayed-Action PreparationsErgocalciferolsFemaleFractures, StressGastric BypassHumansInjections, IntramuscularMiddle AgedObesity, MorbidOsteomalaciaVitamin D DeficiencyBone Density Conservation AgentsDelayed-Action PreparationsErgocalciferolsBariatric SurgeryErgocalciferolOsteomalaciaRoux-en-Y Gastric By-passVitamin D Deficiency

Identifiers

PMID32481245
PMCPMC7288392
OpenAlexW3030723573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.